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LETTERS TO THE EDITOR
Activation of Epidermal Growth Factor Receptor/ERK
Signaling Correlates with Suppressed Differentiation in
Malignant Acanthosis Nigricans
To the Editor:
The homeostasis of the epidermis is regulated by a multitude of
factors that act via speci®c receptors on the keratinocyte surface.
These factors are normally released in a paracrine or autocrine way.
There is a rare condition, however, in which epidermal growth is
thought to be regulated by an endocrine mechanism, i.e., by
growth factors synthesized in tissues other than the skin and
released into the circulation: paraneoplastic or malignant acanthosis
nigricans (MAN).
The pathogenesis of MAN is still unclear. A current hypothetical
mechanism is the secretion of large amounts of transforming
growth factor a (TGF-a) by the tumor into the circulation that is
thought to stimulate keratinocyte growth via an endocrine route
(Koyama et al, 1997). Increased production of TGF-a has been
found in the vast majority of primary bladder carcinomas and in
cells isolated from such tumors (Mellon et al, 1996; Gazzaniga et al,
1998; Ruck and Paulie, 1998; Tungekar and Linehan, 1998), and
there seems to be a positive correlation between tumor stage and
expression levels of this growth factor (Ravery et al, 1997; Kee et al,
2001).
TGF-a is a primary mediator of benign and malignant
keratinocyte hyperproliferation in vivo: upregulation of TGF-a
production and epidermal growth factor receptor (EGFR) expres-
sion have been found in samples of psoriatic human skin (Nanney et
al, 1986; Elder et al, 1989) and in squamous cell carcinomas
(Donnelly et al, 1993; Jones et al, 1993). When overexpressed in the
epidermis of transgenic mice TGF-a induces epidermal thickening
caused by keratinocyte hyperproliferation (Vassar and Fuchs, 1991).
TGF-a is closely related to epidermal growth factor (EGF) and
binds to the same receptor, EGFR (Kramer et al, 1994). This
binding induces activation of the classical mitogen-activated protein
kinase (MAPK, ERK) pathway, a module of three protein kinases
that is organized in a hierarchical fashion and is known to regulate
basic cellular functions such as proliferation, differentiation, and
migration (Marshall, 1994). Our previous studies of ERK activation
in primary human keratinocytes have revealed a role for this
pathway in the regulation of keratinocyte proliferation and
differentiation: sustained activity of ERK suppresses and ERK
inhibition induces differentiation (Haase et al, 2001). Given the role
of ERK in the development of hyperproliferative skin lesions we
asked whether alterations of ERK activity would play a role in the
pathogenesis of MAN.
Biopsies were taken after obtaining informed consent from a
patient suffering from MAN associated with metastatic bladder
carcinoma. The MAN lesions were most pronounced at areas of
corni®ed epithelium bordering the mucosa of lips and eyelids.
Investigations were carried out in samples from the lip of this
patient and in samples of normal skin and normal buccal
mucosa obtained from different individuals. In normal skin and
normal mucosa EGFR is constitutively expressed in the basal
keratinocyte layer and variably in the ®rst and second suprabasal
keratinocyte layer (Fig 1a and data not shown). This expression
pattern was altered dramatically in MAN skin: EGFR was
present on the cell surface of basal and most suprabasal
keratinocytes (Fig 1b, c). Assessment of cell proliferation using
immunostaining against Ki67 and PCNA showed increased
proliferation of basal but not suprabasal keratinocytes in MAN
skin (data not shown). These changes were accompanied by
dramatic alterations in the expression of keratin 14 (K14),
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Figure 1. Expression of EGFR and keratin 14 in acanthosis
nigricans and normal skin. Frozen sections of normal buccal mucosa
(a, d) or MAN skin (b, c, e) were stained with a monoclonal antibody
against EGFR (green staining in a±c; Santa Cruz Biotechnology) or a
monoclonal antibody against human keratin 14 (green in d, e; Progen,
Heidelberg, Germany). Nuclei are shown in red. Magni®cations are the
same for a, c, e, and d; b shows an overview of MAN skin stained for
EGFR at a lower magni®cation. The DNA dye ToProIII and secondary
antibodies coupled to the ¯uorescent dye Alexa 488 (Molecular Probes,
Eugene) were used to visualize nuclei and detected proteins; images were
taken using a Leica TCS upright confocal laser scanning microscope at
excitation wavelengths of 488 and 633 nm. Scale bars: b, 500 mM,
e, 200 mM.
which is normally con®ned to basal keratinocytes (Fig 1d, e). In
MAN lesions K14 was present in all viable, i.e., basal and
suprabasal keratinocytes. Similar changes in keratin expression
have also been found in other hyperproliferative skin conditions
(Wongwaisayawan et al, 1991) and indicate a delayed onset of
terminal differentiation.
Using a combination of Western blotting and confocal laser
scanning microscopy with antibodies that detect phosphorylation-
speci®c epitopes of ERK we analyzed activation of MAPK
signaling in normal skin and mucosa and in MAN lesions.
Western blot analysis of two samples from normal skin and one
sample from MAN skin showed a dramatic increase in the
proportion of phosphorylated, i.e., activated, ERK2 in MAN
skin (Fig 2e and data not shown). This activation was speci®c for
ERK as jun-N terminal kinase (JNK) whose activity is also
regulated by EGFR-dependent signaling (Hashimoto et al, 1999)
showed no signi®cant increase in phosphorylation in the same
sample (Fig 2e). We then used the phosphorylation-speci®c
antibody to localize ERK activity in cryostate sections of MAN
skin and control samples. As reported previously (Haase et al, 2001),
incubation of sections of three different samples of normal skin and
one sample of normal buccal mucosa with the antibody against
activated ERK did not yield any staining above background levels
(Fig 2c, d, and data not shown). In contrast, sections of MAN skin
showed focal staining of nuclei of keratinocytes but not stromal
cells (Fig 2a, b). Keratinocytes in proximity to the stromal parts of
the MAN lesion exhibited most pronounced ERK activation. In
Fig 2(b), which is the same section as in Fig 2(a), nuclei were
visualized using a ¯uorescent nuclear dye, ToProIII (red staining).
The overlap of the green staining for phosphorylated ERK and the
red nuclear staining results in a yellow signal for nuclei containing
activated ERK (Fig 2b).
Binding of TGF-a to EGFR leads to the stimulation of
ERK in many systems (see, for example, Oliver et al, 1995).
Our Western blot analysis clearly shows that levels of total
ERK activity were indeed elevated in MAN skin (Fig 2e). The
®nding that activated ERK was not only present in the basal
compartment but also in suprabasal cells within the lesion
suggests that EGFR expressed suprabasally is functional. In this
context it appears interesting that, in spite of increased ERK
activity in basal and suprabasal cells, proliferation was restricted
to basal keratinocytes. This is consistent with in vitro ®ndings
demonstrating that ERK activation is not suf®cient to stimulate
anchorage-independent growth in primary human keratinocytes
(Haase et al, 2001) and suggests that additional, probably
adhesion-dependent, factors are required in order to translate
the growth stimulating effect of ERK activity. The distribution
of activated ERK within the MAN lesion also raises the
question of which function this pathway exerts in suprabasal
keratinocytes. We have shown recently that, though ERK
activation is not suf®cient to stimulate proliferation of suspended
keratinocytes, it can delay the program of terminal differenti-
ation (Haase et al, 2001). In agreement with that we found
dramatic alterations in the expression of keratin 14 in MAN
skin.
A disturbed balance between proliferation and differentiation of
epidermal keratinocytes is a feature of several skin diseases and we
are only just beginning to understand the intracellular signaling
pathways involved. There is now accumulating evidence for a role
of ERK activation in epidermal hyperproliferation (Albanell et al,
2001; Haase et al, 2001). Here we demonstrate activation of ERK
signaling in a case of MAN and provide further evidence for a
pathogenic role of this pathway in hyperproliferative skin disease.
Ingo Haase, Nicolas Hunzelmann
University of Cologne, Center of Molecular Medicine and
Department of Dermatology, University of Cologne, Germany
Figure 2. Activation of ERK signalling in malignant acanthosis nigricans. Frozen sections of MAN skin (a, b), normal skin (c), or normal
buccal mucosa (d) were stained with an antibody against activated ERK (green signal, Santa Cruz) and images were taken as described in the legend of
Fig 1. To con®rm nuclear localization of the signal the section shown in (a) was stained with the nuclear DNA dye ToProIII (red signal) and both
images were overlayed. Yellow signals in (b) indicate nuclear localization of activated ERK. Magni®cations are the same for (a)±(d); scale bar in (c)
equals 200 mM. (e) Western blot analysis of samples of MAN skin (MAN) and normal skin (N). Blots were incubated with an antibody against
phosphorylated ERK (p-ERK) and reprobed with an antibody against total ERK (ERK) as loading control. Bands in the lower panel represent levels of
activated JNK as determined with a phosphorylation-speci®c antibody (p-JNK). Loading was the same as for p-ERK/ERK. All antibodies were
purchased from Santa Cruz Biotechnology.
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Correlation Analysis of Production and Photoisomerization of
Epidermal Urocanic Acid Versus Induction and Repair of
DNA Photoproducts in the Human Skin In Situ
To the Editor:
Photocarcinogenesis is a complex process comprising the induction
of mutations in cellular DNA by exposure of the skin to ultraviolet
(UV) radiation, the failure of the nucleotide excision repair system
to completely restore the integrity of the genome, and the
concurrent modulation of the cutaneous immune system. The two
important chromophores for UV radiation in the epidermis are
urocanic acid (UCA) and DNA, both considered to be involved in
photocarcinogenesis. Downregulation of the immune system by
DNA damage (Vink et al, 1997) or cis-urocanic acid (cis-UCA)
(Noonan and De Fabo, 1992), the immediate photoisomerization
product of the endogenous trans-UCA, may contribute to the
growth of highly antigenic, UV-induced skin cancers. The
formation and repair of DNA photoproducts as well as the
cutaneous concentration levels of UCA share one interesting
feature in common; they show signi®cant interindividual variation
(Snellman et al, 1997; Bykov et al, 1998). High formation rates or
defective repair of DNA photoproducts in the skin of an individual
with high (cis-)UCA levels would pose an increased risk of UV
tumors. Data on such a possibility are not currently available. We
have compared the induction and repair of DNA photoproducts
and UCA production in the Caucasian skin.
The study was compiled from available data of a total of 17
volunteering subjects (eight females and nine males) who had
earlier been assessed both for photoisomerization of UCA
(Snellman et al, 1999) and for the formation of DNA photoproducts
in situ (Xu et al, 2000a,b,c). Eight of the subjects were previously
treated for cutaneous malignant melanoma (CMM), four for basal
cell carcinoma (BCC), and ®ve were healthy controls (Table I).
UV irradiation was performed with a spectroradiometrically
calibrated solar-simulating UV lamp Philips HP411/A speci®ed
recently (Snellman et al, 1997, 1999; Xu et al, 2000a,b,c). UCA was
sampled both from the protected and UV-exposed [only 10 J per
m2CIE2 (Commission Internationale de l'EÂclairage; McKinlay and
Diffey, 1987) erythemally weighted irradiation dose to avoid the
photostationary state be reached] back skin using the Finn
Chamberâ epidermal sampling (Jansen et al, 1991). The formation
of cyclobutane pyrimidine dimers (CPD) and 6±4 photoproducts in
situ were assessed after an erythemally weighted dose of 400 J per
m2CIE2. This was the highest minimal erythema dose detected in
our probands and high enough for the follow-up of repair rates of
UV photoproducts. Skin biopsies were taken immediately and 24 h
after the exposure and analyzed with the 32P-postlabeling technique
(Bykov and Hemminki, 1995; Bykov et al, 1999).
The levels of photoproducts measured immediately after irradi-
ation showed wide interindividual differences, as did the UCA
levels (Table I). CPD and 6±4 photoproducts were formed with
different ef®cacy, the 6±4 photoproduct levels (TT-T and TT-C)
being 15%±17% of those of CPD, conforming with results of a
larger series (Xu et al, 2000c). A new ®nding, which needs to be
con®rmed in future studies, was that the total UCA concentration
rose in 16 of 17 subjects after UV exposure. This phenomenon may
be a result of a rapid induction of the histidase enzyme either by the
alkaline sampling conditions (Jansen et al, 1991) or by the used
irradiation type and dose, a combination of the two, or it may
re¯ect an acute irradiation-induced change in the epidermal
environment to allow increased diffusion of UCA into the
sampling chambers. We calculated the Pearson's correlation
coef®cients for epidermal total UCA or cis-UCA levels and DNA
photoproducts. Con®dence intervals for correlation were deter-
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